menu
About Us
Classes Of Business
HMO Reinsurance
Provider Excess Of Less
Medical Reinsurance
Employer Stop Loss
Client Captive Programs
Cell & Gene Therapy
Cost Containment
News
Contact Us
News
FDA blesses CellTrans’ Lantidra, the first cell therapy for Type 1 diabetes
on
June 29, 2023
(updated July 5, 2023)
| Category:
News
FDA blesses CellTrans’ Lantidra, the first cell therapy for Type 1 diabetes
Click here to download PDF
